Cognitive impairment in patients with chronic pain syndrome
DOI: 10.32364/2587-6821-2020-4-9-573-577
E.V. Ekusheva
Academy of Postgraduate Education under Federal Research Clinical Center of the Federal Medical-Biological Agency, Moscow, Russian Federation
Belgorod National Research University, Belgorod, Russian Federation
Cognitive impairments and pain syndrome are frequent disorders in the general population and one of the most topical and significant issues of modern medicine faced by doctors of various specialties in clinical practice, both on intpatient and outpatient basis. The article discusses the current understanding of the association and pathogenetic mechanisms concerning cognitive impairment in patients with chronic pain. The most optimal strategies for these patients management are considered, including pharmacological therapy with medication of proven efficacy and various directions of non-drug exposure. The article describes a clinical case of a patient with muscle-tonic and myofascial pain syndromes (6–7 points on VAS scale) and a syndrome of mild cognitive impairment that hindered his professional activity and therefore required therapeutic correction. Correctly selected therapy with the inclusion of analgesics and the nootropic citicoline provided pain relief in the lumbar region, improved concentration and overall well-being.
Keywords: pain syndrome, chronic pain, cognitive impairment, citicoline, choline.
For citation: Ekusheva E.V. Cognitive impairment in patients with chronic pain syndrome. Russian Medical Inquiry. 2020;4(9):573–577. DOI: 10.32364/2587-6821-2020-4-9-573-577.
Acknowledgment
The author and Editorial Board are grateful to LLC Grotex for providing full-text foreign articles required to write the review.
About the author:
Evgeniya V. Ekusheva — Dr. of Sci. (Med.), Professor of the Department of Nervous System Diseases, Academy of Postgraduate Education under Federal Research Clinical Center of the Federal Medical-Biological Agency: 91, Volokolamskoye highway, Moscow, 125371, Russian Federation; Leading Researcher, Belgorod National Research University: 85, Pobedy street, Belgorod, 308015, Russian Federation; ORCID iD 0000-0002-3638-6094.
Contact information: Evgeniya V. Ekusheva, e-mail: ekushevaev@mail.ru. Financial Disclosure: the author has not a financial or property interest in any material or method mentioned. There is no conflict of interests. Received 06.10.2020, revised 20.10.2020, accepted 03.11.2020.
2. Crombie I.К. Epidemiology of persistent pain. Proceedings of the 8-th World Congress on Pain: progress in pain research and management. Vol. 8. T.S. Jensen et al., eds. Seattle: IASP Press; 1997:53–61.
3. Blyth F.M., March L.M., Brnabic A.J. et al. Chronic pain in Australia: a prevalence study. Pain. 2001;89(2–3):127–134. DOI: 10.1016/S0304-3959 (00) 00355-9.
4. Worldwide palliative care alliance (WPCA); World Health Organization 2015 (Electronic resource). URL: http://www.who.int/nmh/Global_Atlas_of_Palliative_Care.pdf. (access date: 03.09.2020).
5. Bjørk M., Sand T. Quantitative EEG power and asymmetry increase 36 h before a migraine attack. Cephalalgia. 2008;28(9):960–968. DOI: 10.1111/j.1468-2982.2008.01638.x.
6. Landrø N.I., Fors E.A., Våpenstad L.L. et al. The extent of neurocognitive dysfunction in a multidisciplinary pain centre population. Is there a relation between reported and tested neuropsychological functioning? Pain. 2013;154(7):972–977. DOI: 10.1016/j.pain.2013.01.013.
7. Eccleston C. Chronic pain and attention: a cognitive approach. Br J Clin Psychol. 1994;33(Pt 4):535–547. DOI: 10.1111/j.2044-8260.1994.tb01150.x.
8. Weiner D.K., Rudy T.E., Morrow L. et al. The relationship between pain, neuropsychological performance, and physical function in community-dwelling older adults with chronic low back pain. Pain Med. 2006;7(1):60–70. DOI: 10.1111/j.1526-4637.2006.00091.x.
9. Morone N.E., Abebe K.Z., Morrow L.A., Weiner D.K. Pain and decreased cognitive function negatively impact physical functioning in older adults with knee osteoarthritis. Pain Med. 2014;15(9):1481–1487. DOI: 10.1111/pme.12483.
10. Van Dijk G.M., Veenhof C., Lankhorst G.J., Dekker J. Limitations in activities in patients with osteoarthritis of the hip or knee: the relationship with body functions, comorbidity and cognitive functioning. Disabil Rehabil. 2009;31(20):1685–1691. DOI: 10.1080/09638280902736809.
11. Schepker C.A., Leveille S.G., Pedersen M.M. et al. Effect of pain and mild cognitive impairment on mobility. J Am Geriatr Soc. 2016;64(1):138–143. DOI: 10.1111/jgs.13869.
12. Brown S.C., Glass J.M., Park D.C. The relationship of pain and depression to cognitive function in rheumatoid arthritis patients. Pain. 2002;96(3):279–284. DOI: 10.1016/S0304-3959 (01) 00457-2.
13. Berryman C., Stanton T.R., Bowering K.J. et al. Evidence for working memory deficits in chronic pain: a systematic review and meta-analysis. Pain. 2013;154(8):1181–1196. DOI: 10.1016/j.pain.2013.03.002.
14. Veldhuijzen D.S., Kenemans J.L., van Wijck A.J.M. et al. Processing capacity in chronic pain patients: a visual event-related potentials study. Pain. 2006;121(1–2):60–68. DOI: 10.1016/j.pain.2005.12.004.
15. Park D.C., Glass J.M., Minear M. et al. Cognitive function in fibromyalgia patients. Arthritis Rheum. 2001;44(9):2125–2133. DOI: 10.1002/1529-0131 (200109) 44:9<2125:: AID-ART365>3.0.CO;2-1.
16. Schiltenwolf M., Akbar M., Hug A. et al. Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids. Pain Physician. 2014;17(1):9–20. PMID: 24452649.
17. Povedano M., Gascón J., Gálvez R. et al. Cognitive function impairment in patients with neuropathic pain under standard conditions of care. J Pain Symptom Manage. 2007;33(1):78–89. DOI: 10.1016/j.jpainsymman.2006.07.012.
18. Hart R.P., Wade J.B., Martelli M.F. Cognitive impairment in patient with chronic pain: significance of stress. Curr Pain Headache Rep. 2003;7:116–126. DOI: 10.1007/s11916-003-0021-5.
19. McCracken L.M., Iverson G.L. Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage. 2001;21(5):392–396. DOI: 10.1016/S0885-3924 (01) 00267-6.
20. Severeijns R., Vlaeyen J.W., van den Hout M.A. et al. Pain catastrophizing predicts pain intensity, disability, and psychological distress independent of the level of physical impairment. Clin J Pain. 2001;17:165–172. DOI: 10.1097/00002508-200106000-00009.
21. Malfliet A., Coppieters I., Wilgen P.V. et al. Brain changes associated with cognitive and emotional factors in chronic pain: A systematic review. Eur J Pain. 2017;21(5):769–786. DOI: 10.1002/ejp.1003.
22. Moriarty O., McGuire B.E., Finn D.P. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011;93(3):385–404. DOI: 10.1016/j.pneurobio.2011.01.002.
23. Apkarian A.V., Sosa Y., Sonty S. et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24(46):10410–10415. DOI: 10.1523/JNEUROSCI.2541-04.2004.
24. Valet M., Gndel H., Sprenger T. et al. Patients with pain disorder show gray-matter loss in pain-processing structures: a voxel-based morphometric study. Psychosomatic Medicine. 2009;71(1):49–56. DOI: 10.1097/PSY.0b013e31818d1e02.
25. Lebel C., Gee M., Camicioli R. et al. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage. 2012;60(1):340–352. DOI: 10.1016/j.neuroimage.2011.11.094.
26. Grachev I.D., Fredrickson B.E., Apkarian A.V. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain. 2000;89(1):7–18. DOI: 10.1016/S0304-3959 (00) 00340-7.
27. Bushnell M.C., Ceko M., Low LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci. 2013;14(7):502–511. DOI: 10.1038/nrn3516.
28. Ford G.K., Moriarty O., McGuire B.E., Finn D.P. Investigating the effects of distracting stimuli on nociceptive behaviour and associated alterations in brain monoamines in rats. Eur J Pain. 2008;12(8):970–979. DOI: 10.1016/j.ejpain.2008.01.002.
29. Rodriguez-Raecke R., Niemeier A., Ihle K. et al. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci. 2009;29(44):13746–13750. DOI: 10.1523/JNEUROSCI.3687-09.2009.
30. Mazza S., Frot M., Rey A.E. A comprehensive literature review of chronic pain and memory. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(Pt B):183–192. DOI: 10.1016/j.pnpbp.2017.08.006.
31. Grieb P. Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs. 2014;28(3):185–193. DOI: 10.1007/s40263-014-0144-8.
32. Secades J.J., Alvarez-Sabín J., Castillo J et al. Citicoline for acute ischemic stroke: a systematic review and formal meta-analysis of randomized, double-blind, and placebo-controlled trials. J Stroke Cerebrovasc Dis. 2016;25(8):1984–1996. DOI: 10.1016/j.jstrokecerebrovasdis.2016.04.010.
33. Yuliani S., Widyarini S., Mustofa, Partadiredja G. Turmeric extract inhibits apoptosis of hippocampal neurons of trimethyltin-exposed rats. Bratisl Lek Listy. 2017;118(3):142–148. DOI: 10.4149/BLL_2017_028.
34. Marston K.J., Brown B.M., Rainey-Smith S.R., Peiffer J.J. Resistance exerciseinduced responses in physiological factors linked with cognitive health. J Alzheimers Dis. 2019;68(1):39–64. DOI: 10.3233/JAD-181079.
35. Bruce S.E., Werner K.B., Preston B.F., Baker L.M. Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage. Int J Food Sci Nutr. 2014;65:1003–1007. DOI: 10.3109/09637486.2014.940286.
36. Екушева Е.В. Сенсомоторная интеграция при поражении центральной нервной системы: клинические и патогенетические аспекты: дис. … д-ра мед. наук. М.; 2016. [Ekusheva E.V. Sensorimotor integration in central nervous system damage: clinical and pathogenetic aspects: thesis. M.; 2016].
37. Secades J.J. Citicoline: pharmacological and clinical review, 2016 update. Rev Neurol. 2016;63(3):1–73.
38. Ye J., Lin H., Mu J. et al. Effect of basic fibroblast growth factor on hippocampal cholinergic neurons in a rodent model of ischaemic encephalopathy. Basic Clin Pharmacol Toxicol. 2010;107(6):931–939. DOI: 10.1111/j.1742–7843.2010.00603.x.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать